ABBV Jun 2024 165.000 call
| Previous close | 0.7400 |
| Open | 0.8200 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 165.00 |
| Expiry date | 2024-06-07 |
| Day's range | 0.5900 - 1.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 803 |
ZacksLilly (LLY) Hits Record High on Crohn's Disease Study Data
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.
PR NewswireAbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®
AbbVie (NYSE: ABBV) announced it is presenting 15 abstracts at the 2024 Digestive Disease Week (DDW) Annual Meeting, being held May 18-21 in Washington, D.C., and virtually.
The Real DealAbbVie CEO latest heavy hitter to buy in Boca Raton
AbbVie's Richard Gonzalez with 650 Tern Point Circle in Boca Raton (Daniel Petroni, AbbVie)AbbVie CEO Richard Gonzalez is the latest heavy hitter to buy in Boca Raton. The pharma boss dropped $14.3 million on a waterfront mansion, following a string of eight-figure deals in the city. Records show Gonzalez bought the house at 650 Tern Point Circle in Boca Raton’s […]The post AbbVie CEO latest heavy hitter to buy in Boca Raton appeared first on The Real Deal.
